A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy Participants
Clinical trial NCT03682380 · COMPLETED
Trial details
- NCT number
- NCT03682380
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2019-08-23
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.